Number of Shares
1,738.00
Current Holdings Value*
$136,500.00
% of Portfolio
2.25%
Total Estimate Gain
$99,240.58
% of Total Estimate Gain
54.50%

BlackRock Defensive Advantage U.S. Fund's Gilead Sciences Inc Holding Summary

As of 2023-10-31, BLACKROCK FUNDS held 1,738.00 shares of Gilead Sciences Inc(GILD), totaling $136,500.00. This investment constitutes 2.25% of their stock portfolio, and BLACKROCK FUNDS now holds 0% of the outstanding Gilead Sciences Inc(GILD) stock.

The initial trade took place in 2021Q1. And since then BlackRock Defensive Advantage U.S. Fund has made 3 purchases of GILD, at an average price of $62.09, for a total of 2,933.00 shares. In addition, there have been 4 sales at an average price of $71.05 for 1,195.00 shares. Based on historical transaction data and GILD's current price of $113.03, BlackRock Defensive Advantage U.S. Fund's estimated gain on his GILD holdings is $99,240.58, reflecting a 54.50% gain to date.

BlackRock Defensive Advantage U.S. Fund GILD ($113.03) Holding Chart

BlackRock Defensive Advantage U.S. Fund GILD ($113.03) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1